#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16984	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2049	817.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1707	1707	T	912	T,C	630,204	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16984	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2049	817.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1441	1441	C	1018	C	932	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31046	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3627	853.1	0	.	n	.	0	T695C	SNP	695	695	T	1076	1076	C	903	C,T	827,5	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31046	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3627	853.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1718	1718	A	1075	A	980	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31046	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3627	853.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2352	2352	C	1015	C,T	926,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31046	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3627	853.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2426	2426	A	960	A	894	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31046	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3627	853.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2978	2978	C	972	C	895	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2206	folP	855	855	100.0	folP.l15.c4.ctg.1	1433	152.3	1	SNP	p	R229S	1	.	.	685	687	AGC	995	997	AGC	219;221;220	A;G,A;C	202;202,1;200	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6128	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3397	179.7	1	SNP	p	S91F	1	.	.	271	273	TTC	624	626	TTC	186;186;180	T;T;C	171;169;166	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6128	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3397	179.7	1	SNP	p	D95G	1	.	.	283	285	GGC	636	638	GGC	176;177;179	G;G;C	161;162;164	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6128	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3397	179.7	1	SNP	p	G95N	0	.	.	283	285	GGC	636	638	GGC	176;177;179	G;G;C	161;162;164	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1948	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1387	139.9	1	SNP	p	G45D	0	.	.	133	135	GGC	555	557	GGC	267;266;268	G;G;C	243;241;245	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	890	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	984	89.7	0	.	n	.	0	A197.	DEL	197	197	A	541	541	A	221	A	208	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6200	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3062	201.6	1	SNP	p	D86N	0	.	.	256	258	GAC	644	646	GAC	270;273;275	G;A;C	246;243;251	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6200	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3062	201.6	1	SNP	p	R87I	0	.	.	259	261	CGT	647	649	CGT	274;275;274	C;G;T	251;253;248	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6200	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3062	201.6	1	SNP	p	R87W	0	.	.	259	261	CGT	647	649	CGT	274;275;274	C;G;T	251;253;248	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6200	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3062	201.6	1	SNP	p	S87R	1	.	.	259	261	CGT	647	649	CGT	274;275;274	C;G;T	251;253;248	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6200	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3062	201.6	1	SNP	p	S88P	0	.	.	262	264	TCC	650	652	TCC	274;273;276	T;C;C	252;249;250	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4984	parE	1986	1986	100.0	parE.l6.c17.ctg.1	2656	186.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1641	1643	GGC	227;222;222	G;G;C	208;204;200	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4640	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2320	198.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1208	1210	GCA	261;262;266	G;C;A	239;239;246	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4640	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2320	198.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1211	1213	ATC	269;269;269	A;T;C	247;248;245	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4640	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2320	198.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1223	1225	GTG	259;259;262	G;T;G	244;244;247	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4640	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2320	198.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1223	1225	GTG	259;259;262	G;T;G	244;244;247	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4640	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2320	198.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1727	1729	ACC	255;255;257	A;C;C	220;228;232	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4640	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2320	198.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1781	1783	GCG	227;224;220	G;C;G	194;179;177	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4640	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2320	198.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1781	1783	GCG	227;224;220	G;C;G	194;179;177	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4640	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2320	198.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1904	1906	AGC	190;190;189	A,G;G;C	173,1;174;170	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4640	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2320	198.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1913	1915	GGC	181;181;183	G;G;C	167;168;168	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4640	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2320	198.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1931	1933	CCG	155;159;159	C,G;C,G;G	119,7;124,2;125	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6664	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2909	227.4	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1340	1342	ACG	259;259;260	A;C;G	231;236;238	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6664	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2909	227.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1478	1480	CCG	248;248;244	C;C;G	214;219;211	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2578	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1809	141.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	586	586	C	181	C	168	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1651	193.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	377	379	GAA	284;283;283	G;A;A	266;264;265	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1651	193.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	665	667	GAT	257;255;253	G;A;T	235;230;229	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1651	193.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	788	790	TCA	285;281;284	T;C;A	257;257;261	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1651	193.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	917	919	GTC	260;260;257	G;T;C,T	243;240;241,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1651	193.9	0	.	p	.	0	F222S	NONSYN	664	666	TTT	929	931	TCT	260;257;258	T,C;C,T;T	247,1;248,1;249	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1651	193.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1247	1249	GCA	264;260;259	G;C;A	243;241;240	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1651	193.9	1	SNP	p	G120K	1	.	.	358	360	AAG	623	625	AAG	256;250;250	A;A;G	231;227;228	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1651	193.9	1	SNP	p	A121D	1	.	.	361	363	GAC	626	628	GAC	248;251;253	G;A;C	225;228;231	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3224	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1651	193.9	1	SNP	p	D121N	0	.	.	361	363	GAC	626	628	GAC	248;251;253	G;A;C	225;228;231	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11970	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4989	239.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1314	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1113	117.6	1	SNP	p	V57M	1	.	.	169	171	ATG	587	589	ATG	261;261;259	A;T;G	242;241;240	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
